Clonazepam treatment of five lithium-refractory patients with bipolar disorder

T A Aronson, Sashi Shukla, Jack Hirschowitz

American Journal of Psychiatry · 1989 · 47 citations · 15 references

Concepts

Abstract

The authors describe the first five patients enrolled in an open clinical trial of clonazepam as a maintenance treatment in lithium-refractory bipolar disorder. All patients relapsed quickly after taking clonazepam (one within 2 weeks and four within 10-15 weeks), and the study was prematurely terminated. The results cast doubt over the usefulness of clonazepam as a prophylaxis in lithium-resistant bipolar patients who have histories of psychotic mania or delusional depression.

References

15